Matches in SemOpenAlex for { <https://semopenalex.org/work/W2090900441> ?p ?o ?g. }
Showing items 1 to 100 of
100
with 100 items per page.
- W2090900441 endingPage "S50" @default.
- W2090900441 startingPage "S50" @default.
- W2090900441 abstract "(EBCTCG)의메타분석을통해50세이하의유방암환자에서15년 Purpose: An in vitro adenosine triphosphate-based chemotherapy response assay (ATP-CRA) was designed to require only a limited number of cells and shorten test turnaround time with a high success rate. This study investigated the correlation between in vitro doxorubicin sensitivity of tumor cells and early systemic recurrence, defined as recurrence within 2 years after surgery. Methods: From January 2004 to March 2007, the ATP-CRA for doxorubicin was tested in 128 patients among breast cancer patients treated at Gangnam Severance Hospital, Seoul, Korea. The American Joint Committee on Cancer stages for all patients were II and III. All patients received doxorubicin-based chemotherapy. Selected patients were divided into a chemosensitive group and a non-chemosensitive group, according to a 40% cell death rate as a cut-off value. We analyzed the relationship between chemosensitivity and early systemic recurrence in patients with breast cancer. Results: The mean age of the patients investigated was 44.6-years-old, the mean follow-up period was 39.9 months, and recurrence free survival was 38.6 months. Thirteen recurrences were observed during follow-up. Among 13 patients with a recurrence, eight had a recurrence within 2 years (early recurrence). All of the early recurring patients belonged to the non-sensitive group. Doxorubicin sensitivity results measured by ATP-CRA were related with early recurrence free survival in patients with breast cancer (p=0.030). The mean cell death rate derived from the ATP-CRA for the early recurrence group tended to be lower than that of the non-early recurrence group, but the difference was not statistically significant (p=0.05). Conclusion: Doxorubicin sensitivity measured by ATP-CRA was well correlated with in vivo drug responsibility to predict early recurrence against doxorubicinbased adjuvant chemotherapy in patients with breast cancer." @default.
- W2090900441 created "2016-06-24" @default.
- W2090900441 creator A5003501245 @default.
- W2090900441 creator A5011892263 @default.
- W2090900441 creator A5021381253 @default.
- W2090900441 creator A5024609610 @default.
- W2090900441 creator A5028543814 @default.
- W2090900441 creator A5033852351 @default.
- W2090900441 creator A5089298785 @default.
- W2090900441 date "2011-01-01" @default.
- W2090900441 modified "2023-10-18" @default.
- W2090900441 title "Correlation of Early Systemic Recurrence withIn VitroAdenosine Triphosphate-Based Chemotherapy Response Assay in Stage II and III Breast Cancer Patients Treated with Doxorubicin-Based Chemotherapy" @default.
- W2090900441 cites W1487783072 @default.
- W2090900441 cites W1941056101 @default.
- W2090900441 cites W1961026612 @default.
- W2090900441 cites W1973043379 @default.
- W2090900441 cites W1974957716 @default.
- W2090900441 cites W1977686559 @default.
- W2090900441 cites W1986167600 @default.
- W2090900441 cites W1997743191 @default.
- W2090900441 cites W2020686935 @default.
- W2090900441 cites W2035156143 @default.
- W2090900441 cites W2037736499 @default.
- W2090900441 cites W2045773071 @default.
- W2090900441 cites W2050629268 @default.
- W2090900441 cites W2055125344 @default.
- W2090900441 cites W2057776946 @default.
- W2090900441 cites W2073604686 @default.
- W2090900441 cites W2077428858 @default.
- W2090900441 cites W2081033831 @default.
- W2090900441 cites W2086955530 @default.
- W2090900441 cites W2100629056 @default.
- W2090900441 cites W2117415503 @default.
- W2090900441 cites W2149011079 @default.
- W2090900441 cites W2169302611 @default.
- W2090900441 cites W2272625050 @default.
- W2090900441 cites W597449721 @default.
- W2090900441 doi "https://doi.org/10.4048/jbc.2011.14.s.s50" @default.
- W2090900441 hasPublicationYear "2011" @default.
- W2090900441 type Work @default.
- W2090900441 sameAs 2090900441 @default.
- W2090900441 citedByCount "1" @default.
- W2090900441 crossrefType "journal-article" @default.
- W2090900441 hasAuthorship W2090900441A5003501245 @default.
- W2090900441 hasAuthorship W2090900441A5011892263 @default.
- W2090900441 hasAuthorship W2090900441A5021381253 @default.
- W2090900441 hasAuthorship W2090900441A5024609610 @default.
- W2090900441 hasAuthorship W2090900441A5028543814 @default.
- W2090900441 hasAuthorship W2090900441A5033852351 @default.
- W2090900441 hasAuthorship W2090900441A5089298785 @default.
- W2090900441 hasBestOaLocation W20909004411 @default.
- W2090900441 hasConcept C117220453 @default.
- W2090900441 hasConcept C121608353 @default.
- W2090900441 hasConcept C126322002 @default.
- W2090900441 hasConcept C143998085 @default.
- W2090900441 hasConcept C146357865 @default.
- W2090900441 hasConcept C151730666 @default.
- W2090900441 hasConcept C2524010 @default.
- W2090900441 hasConcept C2776694085 @default.
- W2090900441 hasConcept C2781303535 @default.
- W2090900441 hasConcept C33923547 @default.
- W2090900441 hasConcept C502942594 @default.
- W2090900441 hasConcept C530470458 @default.
- W2090900441 hasConcept C71924100 @default.
- W2090900441 hasConcept C86803240 @default.
- W2090900441 hasConceptScore W2090900441C117220453 @default.
- W2090900441 hasConceptScore W2090900441C121608353 @default.
- W2090900441 hasConceptScore W2090900441C126322002 @default.
- W2090900441 hasConceptScore W2090900441C143998085 @default.
- W2090900441 hasConceptScore W2090900441C146357865 @default.
- W2090900441 hasConceptScore W2090900441C151730666 @default.
- W2090900441 hasConceptScore W2090900441C2524010 @default.
- W2090900441 hasConceptScore W2090900441C2776694085 @default.
- W2090900441 hasConceptScore W2090900441C2781303535 @default.
- W2090900441 hasConceptScore W2090900441C33923547 @default.
- W2090900441 hasConceptScore W2090900441C502942594 @default.
- W2090900441 hasConceptScore W2090900441C530470458 @default.
- W2090900441 hasConceptScore W2090900441C71924100 @default.
- W2090900441 hasConceptScore W2090900441C86803240 @default.
- W2090900441 hasIssue "Suppl 1" @default.
- W2090900441 hasLocation W20909004411 @default.
- W2090900441 hasOpenAccess W2090900441 @default.
- W2090900441 hasPrimaryLocation W20909004411 @default.
- W2090900441 hasRelatedWork W2348231456 @default.
- W2090900441 hasRelatedWork W2354050160 @default.
- W2090900441 hasRelatedWork W2367105124 @default.
- W2090900441 hasRelatedWork W2371305999 @default.
- W2090900441 hasRelatedWork W2379009234 @default.
- W2090900441 hasRelatedWork W2379151083 @default.
- W2090900441 hasRelatedWork W2388730008 @default.
- W2090900441 hasRelatedWork W2782589310 @default.
- W2090900441 hasRelatedWork W2791179561 @default.
- W2090900441 hasRelatedWork W4306163962 @default.
- W2090900441 hasVolume "14" @default.
- W2090900441 isParatext "false" @default.
- W2090900441 isRetracted "false" @default.
- W2090900441 magId "2090900441" @default.
- W2090900441 workType "article" @default.